Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Chronic-Phase 4Breast Neoplasms 2Pancreatic Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Bronchiolitis Obliterans Syndrome 1Blast Crisis 1Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

Cyclophosphamide 12fludarabine phosphate 11Peripheral Blood Stem Cell Transplantation 10Cyclosporine 9Antilymphocyte Serum 9Methotrexate 8Busulfan 8Tacrolimus 7Radiotherapy 7Whole-Body Irradiation 6Mycophenolic Acid 6Filgrastim 6Methylprednisolone 5Cord Blood Stem Cell Transplantation 5Sirolimus 4Melphalan 4Flow Cytometry 4Thiotepa 3Rituximab 3Imatinib Mesylate 3Dasatinib 3Sunitinib 2Moxifloxacin 2Leucovorin 2Immunosuppression Therapy 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Cytarabine 2Bortezomib 2Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Accelerated Phase × bosutinib × Clear all
NCT02782403 2020-11-19

Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
Other hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡